[HTML][HTML] Role of microRNAs as clinical cancer biomarkers for ovarian cancer: a short overview
Ovarian cancer has the highest mortality rate among gynecological cancers. Early clinical
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
[PDF][PDF] Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview
CE Staicu, DV Predescu, CM Rusu, B Mihaela - researchgate.net
Ovarian cancer has the highest mortality rate among gynecological cancers. Early clinical
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview
CE Staicu, DV Predescu, CM Rusu, BM Radu… - Cells, 2020 - pubmed.ncbi.nlm.nih.gov
Ovarian cancer has the highest mortality rate among gynecological cancers. Early clinical
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview
CE Staicu, DV Predescu, CM Rusu, BM Radu… - 2020 - agris.fao.org
Ovarian cancer has the highest mortality rate among gynecological cancers. Early clinical
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
[PDF][PDF] Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview
SC Voinea - pdfs.semanticscholar.org
Ovarian cancer has the highest mortality rate among gynecological cancers. Early clinical
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview
CE Staicu, DV Predescu, CM Rusu, BM Radu… - Cells, 2020 - search.proquest.com
Ovarian cancer has the highest mortality rate among gynecological cancers. Early clinical
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
[PDF][PDF] Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview
SC Voinea - academia.edu
Ovarian cancer has the highest mortality rate among gynecological cancers. Early clinical
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview.
CE Staicu, DV Predescu, CM Rusu, BM Radu… - Cells, 2020 - europepmc.org
Ovarian cancer has the highest mortality rate among gynecological cancers. Early clinical
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview.
CE Staicu, DV Predescu, CM Rusu… - Cells (2073 …, 2020 - search.ebscohost.com
Ovarian cancer has the highest mortality rate among gynecological cancers. Early clinical
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
[HTML][HTML] Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview
CE Staicu, DV Predescu, CM Rusu, BM Radu… - Cells, 2020 - ncbi.nlm.nih.gov
Ovarian cancer has the highest mortality rate among gynecological cancers. Early clinical
signs are missing and there is an urgent need to establish early diagnosis biomarkers …
signs are missing and there is an urgent need to establish early diagnosis biomarkers …